Similarly, a case study involving the treatment of a cachectic advanced lung cancer patient with the anti‐IL‐6R monoclonal antibody tocilizumab resulted in significant weight gain, yet tumor growth continued unabated, leading to subsequent metastases.865. This evidence concerns the gene IL6R and lung carcinoma.